UBS Group’s Vicarious Surgical Inc Warrants RBOT.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-1,199
| Closed | -$24 | – | 11057 |
|
|
2025
Q3 | $24 | Buy |
1,199
+991
| +476% | +$32 | ﹤0.01% | 10116 |
|
|
2025
Q2 | $6 | Buy |
+208
| New | +$6 | ﹤0.01% | 10170 |
|
|
2025
Q1 | – | Sell |
-474
| Closed | -$12 | – | 10635 |
|
|
2024
Q4 | $12 | Buy |
+474
| New | +$17 | ﹤0.01% | 9805 |
|
|
2024
Q2 | – | Sell |
-182
| Closed | -$16 | – | 9989 |
|
|
2024
Q1 | $16 | Buy |
+182
| New | +$17 | ﹤0.01% | 9057 |
|
|
2023
Q1 | – | Sell |
-15,842
| Closed | -$2.38K | – | 10245 |
|
|
2022
Q4 | $2.38K | Buy |
+15,842
| New | +$5.89K | ﹤0.01% | 9689 |
|
|
2022
Q2 | – | Sell |
-600
| Closed | -$1K | – | 10817 |
|
|
2022
Q1 | $1K | Sell |
600
-9,742
| -94% | -$9.77K | ﹤0.01% | 9908 |
|
|
2021
Q4 | $22K | Buy |
10,342
+6,394
| +162% | +$13K | ﹤0.01% | 7738 |
|
|
2021
Q3 | $9K | Buy |
+3,948
| New | +$7.97K | ﹤0.01% | 8107 |
|
UBS Group's RBOT.WS Position: Q4 2025 in Review
UBS Group sold out of Vicarious Surgical Inc Warrants (RBOT.WS) in Q4 2025, closing a stake of 1,199 shares — an estimated $24 sold.
UBS Group first reported a position in RBOT.WS in Q3 2021 and held it in 8 quarters. The position peaked at $22K in Q4 2021. 0 funds tracked by Wall St. Rank hold RBOT.WS as of Q4 2025.
- UBS Group reported no remaining Vicarious Surgical Inc Warrants position as of Q4 2025 after selling out during the quarter.
- UBS Group sold 1,199 Vicarious Surgical Inc Warrants shares in Q4 2025, an estimated $24.
- UBS Group first reported a position in Vicarious Surgical Inc Warrants in Q3 2021 and held it in 8 quarters.
- UBS Group's Vicarious Surgical Inc Warrants position peaked at $22K in Q4 2021.
- 0 funds tracked by Wall St. Rank held Vicarious Surgical Inc Warrants as of Q4 2025.
Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.